Today: 11 June 2026
Goldman Sachs stock slides into weekend after CEO pay hits $47 million — what to watch next
24 January 2026
2 mins read

Goldman Sachs stock slides into weekend after CEO pay hits $47 million — what to watch next

New York, Jan 24, 2026, 05:50 EST — Market closed.

  • Goldman Sachs shares dropped 3.75% on Friday, ending the day at $918.88 following a volatile session with swings exceeding $20.
  • A regulatory filing revealed CEO David Solomon’s compensation for 2025 climbed to $47 million, driven largely by stock awards.
  • Investors are entering Monday with a sharp eye on policy risks and the upcoming earnings reports that could validate current market valuations.

Shares of Goldman Sachs Group Inc fell 3.75% to close at $918.88 on Friday, with intraday swings between $917.05 and $937.19. After-hours trading saw little movement, keeping the stock flat.

The decline is significant since Goldman serves as a key Wall Street indicator, with its shifts often influencing broader sentiment around dealmaking and market liquidity.

This comes just before a busy week packed with catalysts, a period when traders often crack down on anything that seems like “too much” — whether that’s pricing, risk, or optimism — particularly in financial stocks.

The Dow slipped 0.58% on Friday, while the S&P 500 barely moved, dragged down by Intel’s 17% plunge after a grim forecast, Reuters reports. “We feel pretty good about where we are today,” said Jason Blackwell, chief investment strategist at Focus Partners Wealth. Julian McManus, portfolio manager at Janus Henderson, described the market as entering a “show-me” phase. Investing.com

Goldman revealed in a Form 8-K that its board pegged CEO David Solomon’s 2025 compensation at $47 million, rising from $39 million the previous year. The breakdown: $2 million salary and $45 million in variable pay. This includes $31.5 million in performance share units tied to firmwide goals, $10.1 million in cash, and $3.4 million linked to a carried-interest program. The committee pointed to a 57% total shareholder return in 2025, combining share gains and dividends. They also noted the firm reported $58.28 billion in net revenue, $17.18 billion in net earnings, and a 15% return on equity.

Solomon’s pay package outstripped JPMorgan Chase CEO Jamie Dimon’s $43 million reported just a day before, Reuters noted. Goldman also appointed President and COO John Waldron to its board, signaling him as a likely successor, the outlet added. Goldman’s stock climbed 53.5% in 2025, according to Reuters.

Goldman Sachs raised its gold price target for the end of 2026 to $5,400 an ounce, up from $4,900. The bank pointed to private investors and central banks in emerging markets shifting their portfolios toward bullion.

Goldman investors are now watching to see if volatility will sustain market activity or bring underwriting and merger talks to a halt. Friday’s sharp intraday swings highlighted just how fast risk appetite can shift.

Yet the setup works both ways. A sudden jump in bond yields or fresh trade-related turmoil could drag down equities and client activity simultaneously — a tough scenario for any investment bank.

The Federal Reserve’s two-day meeting on Jan. 27-28 is the next major event on the calendar. The Fed has scheduled its announcement for 2:00 p.m. on Jan. 28, followed by a press conference at 2:30 p.m. U.S. markets will reopen Monday, Jan. 26, with investors closely monitoring whether bank stocks continue to slide after Friday’s selloff.

Stock Market Today

  • Banco BPM Stock Valuation Reviewed as Shares Rise Amid Earnings Momentum
    June 11, 2026, 11:13 AM EDT. Banco BPM (BIT:BAMI) has posted robust share price gains of 8.85% in the past month and 51.01% over the last year, driven by strong earnings with revenue of €5.42 billion and net income of €2.05 billion. Despite recent appreciation, analysts see the stock as slightly overvalued at a consensus fair value of €13.71, below the current price of €14.03. Banco BPM trades at a price-to-earnings (P/E) ratio of 10.3 times, below European bank peers at 11.3 times, suggesting some valuation cushion. However, risks such as increased fintech competition and challenges in cost efficiencies remain. Investor focus is on whether current momentum fully reflects growth expectations or leaves room for further upside.

Latest articles

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

Theriva Biologics Pops on VCN-01 Study Results, Gets Traders’ Attention

11 June 2026
TOVX soared 74.6% to $0.4252 after Theriva Biologics published Phase 1 VCN-01 data showing survival and biomarker signals in head-and-neck cancer, but the jump was not due to drug approval or revenue; investors face ongoing financing, dilution, and clinical-trial execution risks, with the company’s cash runway only into Q1 2027 and substantial doubt about its ability to continue as a going concern without new capital.
Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

Trulieve Stock Turns Heads on NYSE After $50 Million Buyback

11 June 2026
Trulieve began NYSE trading as TRLV this week after moving from OTC/CSE, authorized a buyback of up to $50 million or 8.5 million shares, and closed its first NYSE session at $11.50, down 0.43%, before trading near $11.78 early Thursday, as investors weigh whether the uplisting and buyback will boost demand amid ongoing federal cannabis policy uncertainty.
Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

Propanc Biopharma Jumps on $5 Million Buyback Plan, Investors React

11 June 2026
Propanc Biopharma shares soared as much as 392% after authorizing up to $5 million in stock buybacks—exceeding its prior $3.1 million equity value—even as it reported just $443,702 in cash and flagged going-concern risks, with investors now focused on whether its lead cancer drug PRP will advance to a planned Phase 1b trial this year.
Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings
Previous Story

Fortinet stock jumps on TD Cowen upgrade — what FTNT investors watch before earnings

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week
Next Story

Exxon stock price: XTO’s Eagle Ford sale push puts XOM in play ahead of key week

Go toTop